Has anyone documented the extent of sertraline
crossreactivity with benzodiazepine urine drug screening
methods, specifically the Abbott AxSYM method?
Abbott's package insert says only that 1,000,000 ng/mL
sertraline (5-20 times the [parent + metabolites]
concentration expected on a recommended dose) will nudge
the result above the baseline (with no hint as to how far
above the baseline -- to the cutoff? beyond the cutoff?)
Maybe the FDA could suggest how Abbott might improve the
usefulness of their package inserts.
Robert Murray
Lutheran General Hospital
Park Ridge, Illinois
USA
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|